J Woody

Author PubWeight™ 29.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995 4.39
2 Separation of suppressor and killer T cells by surgace phenotype. Nature 1976 3.03
3 T-T interactions in the induction of suppressor and helper T cells: analysis of membrane phenotype of precursor and amplifier cells. J Exp Med 1977 2.22
4 Isolated L4-L5 fusions using the variable screw placement system: unilateral versus bilateral. J Spinal Disord 1992 1.45
5 In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. J Immunol 1996 1.21
6 Partial primary structure of the alpha and beta chains of human tumor T-cell receptors. Science 1985 1.19
7 Serological evidence of arboviral infections among humans of coastal Kenya. J Trop Med Hyg 1991 1.19
8 Primary structure of papain-solubilized human histocompatibility antigen HLA-B27. Biochemistry 1985 1.12
9 Current concepts of the antibody response: heterogeneity of lymphoid cells, interactions, and factors. Cold Spring Harb Symp Quant Biol 1977 1.11
10 Selective production of human antigen specific helper factor from normal volunteers: implications for human Ir genes. Clin Exp Immunol 1979 0.97
11 Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-alpha antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease. Haemostasis 1998 0.94
12 Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens. Arthritis Rheum 1996 0.93
13 Characterization of the immunosuppressive state during Schistosoma mansoni infection. J Immunol 1979 0.90
14 Endovascular exclusion of descending thoracic aortic aneurysms and chronic dissections: Initial clinical results with the AneuRx device. J Vasc Surg 2001 0.88
15 Efficacy of flexion and extension treatments incorporating braces for low-back pain patients with retrodisplacement, spondylolisthesis, or normal sagittal translation. Spine (Phila Pa 1976) 1993 0.84
16 Human T-cell responses in vitro: cell interactions and factors. Ann N Y Acad Sci 1979 0.82
17 Treatment with a chimeric CD4 monoclonal antibody is associated with a relative loss of CD4+/CD45RA+ cells in patients with rheumatoid arthritis. J Autoimmun 1997 0.81
18 Oral desensitization in Rh disease. Am J Obstet Gynecol 1983 0.80
19 Computed tomography assessment of abdominal aortic aneurysm morphology after endograft exclusion. J Vasc Surg 2001 0.80
20 Evaluation of human cultured lymphoblasts as a source of antigen for production of immunosuppressive antilymphocyte serum. Transplant Proc 1973 0.79
21 Aztreonam in the treatment of enteric fevers. Ann Trop Med Parasitol 1987 0.78
22 Treatment of acute toxaemic fascioliasis. Trans R Soc Trop Med Hyg 1988 0.78
23 Praziquantel and acute urban schistosomiasis. Trop Geogr Med 1989 0.76
24 Updating the nurses' bedside manner. Image J Nurs Sch 1993 0.75
25 The diagnosis and treatment of acute toxaemic schistosomiasis in children. Trans R Soc Trop Med Hyg 1987 0.75
26 The treatment and outcome of intracranial infections of otogenic origin. J Trop Med Hyg 1988 0.75
27 Abdominal pain and hemoperitoneum: sole presenting symptoms for "leaking AAA" after endovascular repair. J Endovasc Ther 2001 0.75
28 In vitro binding studies of anti-human lymphocyte globulin: analysis of samples tested for immunosuppression in the primate skin allograft system. J Immunol Methods 1977 0.75
29 MLC and CMC reactivity and specificity of idiotype-specific lymphoid cells enriched for histocompatibility (H-2) antigens. Transplant Proc 1979 0.75
30 Failed AAA endograft exclusion due to type II endoleak: explant analysis. J Endovasc Ther 2001 0.75
31 My brother was a person. He also had AIDS. RN 1988 0.75
32 A clinical report of J.A.: a child with a chronic brain dysfunction. J Sch Health 1969 0.75